Quintiles Wins Pfizer Development Operations Strategic Supplier Excellence Award

RESEARCH TRIANGLE PARK, N.C.--(Business Wire)--
Quintiles Transnational Corp. today announced that its Data Management division
has received the 2008 Pfizer Development Operations` Strategic Supplier
Excellence Award.

Pfizer presents the award to their Development Operations Functional Service
Providers (FSPs) that demonstrate consistent and excellent performance in four
areas: quality; service delivery and reliability; innovation and business
processes; and customer service and responsiveness.

"Quintiles has consistently demonstrated superior performance and partnership by
working to reduce timelines and streamline processes, adding high value to the
Data Management business," said Rob Goodwin, Vice President of Global Clinical
Data Services, Pfizer.

Quintiles executives said the value of the partnership is enhanced by the
strength of the Pfizer-Quintiles relationship.

"The Pfizer and Quintiles teams have worked closely together to lock databases
ahead of schedule, increase productivity and achieve cost savings," said Theo
Erasmus, Vice President, Global Data Management, Quintiles Africa, who heads the
FSP with Pfizer. "A major reason for our successful relationship is proactive
communication. By maintaining an open dialogue, we`ve been able to increase
quality, improve processes and encourage innovation."

"We are honored and delighted to be selected for this award because it
recognizes what can be achieved through open, honest collaboration and
teamwork," said Paula Brown Stafford, Executive Vice President, Integrated
Clinical Services, Quintiles. "We look forward to building an even stronger
relationship with our colleagues at Pfizer and building on our successes for
2009."

Quintiles supports Pfizer data management primarily from locations in
Bloemfontein, South Africa and Bangalore, India.

About Quintiles

Quintiles is the only fully integrated biopharmaceutical services company
offering clinical, commercial, consulting and capital solutions worldwide. The
Quintiles network of 23,000 engaged professionals in more than 50 countries
around the globe works with an unwavering commitment to patients, safety and
ethics. Quintiles helps biopharmaceutical companies navigate risk and seize
opportunities in an environment where change is constant. For more information,
please visit www.quintiles.com.

Quintiles Transnational Corp.
Dick Jones, Media Relations (media.info@quintiles.com)
Greg Connors, Investor Relations (invest@quintiles.com)
919-998-2000

Copyright Business Wire 2009